Section Arrow
Quote
FNA.NYSE
- Paragon 28
Quotes are at least 15-min delayed:2025/04/30 03:54 EDT
Last
 --
-- (--)
Day High 
-- 
Prev. Close
13.09 
1-M High
13.11 
Volume 
-- 
Bid
--
Ask
--
Day Low
-- 
Open
-- 
1-M Low
12.96 
Market Cap 
1.10B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 13.03 
20-SMA 13.03 
50-SMA 13.03 
52-W High 13.13 
52-W Low 4.65 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-0.66/-0.31
Enterprise Value
1.21B
Balance Sheet
Book Value Per Share
1.56
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
256.18M
Operating Revenue Per Share
2.47
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed：2025/04/30 03:54 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of revenue from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.